Trademark Overview
On Thursday, May 29, 2025, a trademark application was filed for ETCAMAH with the United States Patent and Trademark Office. The USPTO has given the ETCAMAH trademark a serial number of 99208291. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 29, 2025. This trademark is owned by AstraZeneca AB. The ETCAMAH trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal, and immune systems; Vaccines; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Antibodies for medical purposes; Pharmaceutical preparations for use in oncology